Recruiting

Observational Study

Sponsor:

RAI Services Company

Code:

NCT07938320

Conditions

Smoking

Tobacco

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Accepted

Interventions

FT254421

FT25631

FT25625

FT25629

FT25628

Study Details

Brief summary:

This is a multi-site, open-label, randomized study to measure puffing topography of generally healthy adult smokers of cigarettes when provided with an electronic nicotine delivery system over a 14-day period of product use.

Conditions

Smoking

Tobacco

Study ID

NCT07938320

Start date

Oct 15, 2026

Status verified date

Oct, 2026

Completion date

Jan, 2027

Anticipated

Primary completion date

Jan, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Able to read, understand, and be willing to sign an informed consent form (ICF) and complete questionnaires written in English
  • Generally healthy males, females, intersex, or 'unknown', age 21-65 years (inclusive at the time of informed consent), verified with government-issued identification
  • All females and those who identify as "intersex" or "unknown" must have a negative pregnancy test at screening and affirm at the SEV that they are not pregnant or intending to become pregnant
  • Self-report currently smoking at least five CPD on smoking days in the past 30 days
  • Smoke CC on 15 or more of the past 30 days
  • Have smoked at least 100 factory-made filtered CC in their lifetime prior to SEV
  • Indicate a willingness to use ENDS
  • Agree to participate in the study and to abide by the study restrictions and requirements, including the use of the assigned Study IP, as described in the ICF
  • Agree not to allow any other person to use any product provided to them for use during this study

Exclusion Criteria:

  • Females who self-report they are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months from the study start date
  • Males who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of signing the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children
  • Females who self-report not using adequate methods to prevent pregnancy (Use of contraceptives or abstinence)
  • Individuals who self-report having pacemakers or other embedded electronic medical devices
  • Individuals who self-report having an unstable heart condition, severe hypertension, or diabetes
  • Individuals who self-report they are allergic/sensitive to cosmetics or fragrances or any ingredient listed in commercial e-cigarette products
  • Individuals who self-report they are sensitive to nicotine
  • Individuals who self-report physical or mental health
  • Individuals who have used ENDS, nicotine pouch, smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, heated tobacco products, or other combustible products and other oral nicotine products (tablets, gums, and lozenges) on 11 or more days in the past 30 days
  • Individuals who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days
  • Individuals who are employed by a company that manufactures tobacco, ENDS, marketing or in ongoing litigation with a tobacco company
  • Individuals who self-report that they are planning to quit all nicotine products in the next three months
  • Individuals who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or ENDS products
  • Individuals who have taken part in a tobacco/nicotine research study in the past 30 days

Study Design

Enrollment

200 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

active comparator: Device Two and NTNM

FT25625 and Non-Tobacco Non-Menthol SKU (FT254421)

active comparator: Device Four and Tobacco SKU

FT25629 and Tobacco SKU (FT25631)

active comparator: Device Four and Non-Tobacco Non-Menthol SKU

FT25629 and NTNM SKU (FT254421)

active comparator: Device Four (Fixed) and Non-Tobacco Non-Menthol SKU

FT25628 and NTNM SKU (FT254421)

Interventions

FT254421

Non-Tobacco Non-Mint/Menthol SKU

FT25631

Tobacco SKU

FT25625

Device Two

FT25629

Device Four

FT25628

Device Four (fixed)

Primary outcome measure

  • To descriptively characterize the user puffing topography measures (Session and Puff characteristics) of primary CC smokers when using one of two Vuse Pro Power Units and one of two e-liquid cartridges with the same nicotine concentration. [ Time Frame: 14 days ]

Central Contacts and Locations

Central contacts

Locations

Sago Phoenix

Recruiting

Phoenix, Arizona, United States, 85016

WAC

Recruiting

Doral, Florida, United States, 33178

L&E Research Tampa

Recruiting

Tampa, Florida, United States, 33634

More Information

Sponsor

RAI Services Company

Last update posted

Nov 16, 2026

Last verified

Oct, 2026

Keywords

  • Tobacco Harm Reduction
  • Smoking
  • Tobacco Use
  • Tobacco Smoking

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by RAI Services Company on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.